Metabolic effects of switching Kaletra [lopinavir/ritonavir] to boosted Reyataz [atazanavir]
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Atazanavir (Primary) ; Lopinavir/ritonavir; Ritonavir
- Indications HIV infections
- Focus Pharmacodynamics
- 10 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 22 Jan 2008 The expected completion date for this trial is now 1 Dec 2008 as reported by ClinicalTrials.gov.
- 10 Jan 2007 New trial record.